Literature DB >> 11152843

Prognostic value of peak exercise systolic blood pressure on long-term survival after myocardial infarction.

J Dorn1, J Naughton, D Imamura, M Trevisan.   

Abstract

This study examined the association between peak exercise systolic blood pressure and other exercise test parameters and the long-term (19-year) survival of 625 patients with myocardial infarction who were original participants of the National Exercise and Heart Disease Project, a 3-year (1976 to 1979) multicenter randomized exercise clinical trial. Results show that low peak exercise systolic blood pressure (< or =140 mm Hg) was associated with increased mortality throughout the 19 years of follow-up, and men with this finding obtained no survival benefit from participating in an exercise program.

Entities:  

Mesh:

Year:  2001        PMID: 11152843     DOI: 10.1016/s0002-9149(00)01320-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Mental Distress Factors and Exercise Capacity in Patients with Coronary Artery Disease Attending Cardiac Rehabilitation Program.

Authors:  Nijole Kazukauskiene; Julius Burkauskas; Jurate Macijauskiene; Inga Duoneliene; Vaidute Gelziniene; Vilija Jakumaite; Julija Brozaitiene
Journal:  Int J Behav Med       Date:  2018-02

2.  The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.

Authors:  Dean Patterson; Robert Kloner; Mark Effron; Jeffrey Emmick; Alun Bedding; Margaret Warner; Malcolm Mitchell; Simon Braat; Thomas MacDonald
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

3.  Hemodynamic variables during stress testing can predict referral to early catheterization but failed to show a prognostic impact on emerging cardiac events in patients aged 70 years and older undergoing exercise (99m)Tc-sestamibi myocardial perfusion scintigraphy.

Authors:  Jan Bucerius; Alexius Y Joe; Ellen Herder; Holger Brockmann; Kim Biermann; Holger Palmedo; Klaus Tiemann; Hans-Jürgen Biersack
Journal:  Int J Cardiovasc Imaging       Date:  2009-04-21       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.